NYSE American - Nasdaq Real Time Price USD

CEL-SCI Corporation (CVM)

1.4500 -0.0600 (-3.97%)
As of 11:24 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Expense
30,311.4120
31,476.0740
36,062.7930
36,194.1290
28,985.0550
Operating Income
-30,311.4120
-31,476.0740
-36,062.7930
-36,194.1290
-28,985.0550
Net Non Operating Interest Income Expense
-720.3230
-675.4160
-1,081.0340
-1,149.2880
-1,041.7250
Other Income Expense
-18.5830
-42.8130
443.1460
982.3080
-228.4640
Pretax Income
-31,050.3180
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Net Income Common Stockholders
-31,050.3180
-32,365.8550
-37,629.8030
-36,711.9700
-30,276.9780
Average Dilution Earnings
--
--
--
-1,085.5400
--
Diluted NI Available to Com Stockholders
-31,050.3180
-32,365.8550
-37,629.8030
-37,797.5100
-30,276.9780
Basic EPS
-0.69
-0.73
-0.87
-0.90
-0.82
Diluted EPS
-0.69
-0.73
-0.87
-0.90
-0.82
Basic Average Shares
45,737.4180
44,479.8650
43,148.8880
40,662.1370
36,759.1150
Diluted Average Shares
45,737.4180
44,479.8650
43,148.8880
40,694.2480
36,759.1150
Total Operating Income as Reported
-30,311.4120
-31,476.0740
-36,062.7930
-36,194.1290
-28,985.0550
Total Expenses
30,311.4120
31,476.0740
36,062.7930
36,194.1290
28,985.0550
Net Income from Continuing & Discontinued Operation
-31,050.3180
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Normalized Income
-31,050.3180
-32,194.3030
-37,067.4720
-37,351.6300
-29,100.4130
Interest Expense
720.3230
675.4160
1,081.0340
1,149.2880
1,041.7250
Net Interest Income
-720.3230
-675.4160
-1,081.0340
-1,149.2880
-1,041.7250
EBIT
-30,329.9950
-31,518.8870
-35,619.6470
-35,211.8210
-29,213.5190
EBITDA
-26,355.5710
-27,560.5530
-31,790.7300
-32,980.7130
-27,053.7900
Reconciled Depreciation
3,974.4240
3,958.3340
3,828.9170
2,231.1080
2,159.7290
Net Income from Continuing Operation Net Minority Interest
-31,050.3180
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Total Unusual Items Excluding Goodwill
--
--
366.7910
990.5210
-1,154.8310
Total Unusual Items
--
--
366.7910
990.5210
-1,154.8310
Normalized EBITDA
-26,355.5710
-27,560.5530
-32,157.5210
-33,971.2340
-25,898.9590
9/30/2020 - 12/8/1983

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NWBO Northwest Biotherapeutics, Inc.
0.4740
-1.27%
 
CTXR Citius Pharmaceuticals, Inc.
0.7914
+7.79%
 
RVPH Reviva Pharmaceuticals Holdings, Inc.
3.1550
+2.09%
 
CARM Carisma Therapeutics, Inc.
1.8200
-2.65%
 
ANVS Annovis Bio, Inc.
12.06
+4.96%
 
BYSI BeyondSpring Inc.
2.2375
+6.04%
 
EYEN Eyenovia, Inc.
0.5231
+1.28%
 
ACOGF Alpha Cognition Inc.
0.5073
-1.59%
 
UNCY Unicycive Therapeutics, Inc.
1.1398
-0.89%
 
ACET Adicet Bio, Inc.
2.1100
+5.50%